Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11892-016-0713-y.pdf
Reference27 articles.
1. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532–9.
2. American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(1):S11–63.
3. Taler SJ, Agarwal R, Bakris GL, Flynn JT, Nilsson PM, Rahman M, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis. 2013;62(2):201–13. This is an update of the International Kidney guidelines (KDIGO) for blood pressure and kidney disease management.
4. Yamout H, Lazich I, Bakris GL. Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):281–6.
5. Standards of medical care in diabetes—2015: summary of revisions. Diabetes care. 2015 Jan;38 Suppl:S4. PubMed American Diabetes Association annual update of blood pressure goals in diabetes
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adenosine reuptake inhibition reduces diabetes-induced glomerular hyperfiltration via the adenosine A2a receptor;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2023-10-01
2. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns;Endocrine Reviews;2023-06-26
3. Niclosamide from an anthelmintic drug to a promising adjuvant therapy for diabetic kidney disease: randomized clinical trial;Diabetology & Metabolic Syndrome;2023-02-16
4. Renoprotective Effects of Angiotensin-Converting Enzyme Inhibitors (Acei) And/Or Angiotensin Ii Receptor Blockers (Arb) in Diabetic Kidney Disease;2023
5. Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression;Frontiers in Immunology;2022-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3